SABCS Snippets: Primary analysis of HER2CLIMB-02


Estimated Read Time:

1 minute

Sara Hurvitz, MD, FACP, Senior Vice President and director of the Clinical Research at Fred Hutchinson Cancer Center, speaks to SABCS Program Director Kate Lathrop, MD, about the primary analysis of HER2CLIMB-02: Tucatinib and Trastuzumab Emtansine for HER2-Positive Metastatic Breast Cancer.